23-valent Pneumococcal PolysaccharideVaccine

23-valent Pneumococcal PolysaccharideVaccine

Products
23-valent Pneumococcal PolysaccharideVaccine
23-valent Pneumococcal PolysaccharideVaccine

Information

Covers a wider range of pneumococcal serotypesMore economical for low-and middle-income countries Patented process Great immunogenicity and safety Prefilled Syringe
All categories
Generic Sera and VaccinesAPIs (Active Pharmaceutical Ingredients)Anatomical Therapeutic Chemical (ATC) Classification ProductsAntiinfectives for Systemic useVaccinesInnovative APIsProducts
Main Categories
APIs (Active Pharmaceutical Ingredients)Anatomical Therapeutic Chemical (ATC) Classification Products
Chongqing Zhifei Biological Products Co., Ltd.Chongqing Zhifei Biological Products Co., Ltd. is the largest listed vaccine company in China，which has its presence in biological product industry in 2002.The Company achieved an operating income of USD7.2 billion in 2023 with the support of its nearly 8000 employees.As a high-tech biological enterprise integrating the R&D, production, marketing, distribution as well as import & export, Zhifei mainly engages in the production of vaccines，antibody，insulin and so on. Our research channels cover many indications extensively: like tuberculosis, meningitis,diabetes etc.

Log in

See all the content and easy-to-use features by logging in or registering!